Cardiovascular magnetic resonance in acute st-segment-elevation myocardial infarction: Recent advances, controversies, and future directions

Circulation

Volumn 137, Issue 18, 2018, Pages 1949-1964

  Bulluck, Heerajnarain ^a,b   Dharmakumar, Rohan ^c,d   Arai, Andrew E ^e   Berry, Colin ^f   Hausenloy, Derek J ^a,g,h,i,j,k  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g ROYAL LONDON HOSPITAL   (United Kingdom)

^h ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

ⁱ DEPARTMENT OF CARDIOLOGY   (Singapore)

^j NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^k NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

more..

Author keywords

Hemorrhage; Magnetic resonance imaging; Percutaneous coronary intervention; ST elevation myocardial infarction

Indexed keywords

FERRITIN; GADOLINIUM; OXYHEMOGLOBIN;

ALL CAUSE MORTALITY; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL OUTCOME; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY OCCLUSION; DNA FINGERPRINTING; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HUMAN; IMAGE ENHANCEMENT; INTRAMYOCARDIAL HEMORRHAGE; ISCHEMIC POSTCONDITIONING; METABOLOMICS; MICROVASCULAR OBSTRUCTION; MYOCARDIAL EDEMA; MYOCARDIAL SALVAGE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REPERFUSION INJURY; SPECKLE TRACKING ECHOCARDIOGRAPHY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; CARDIAC MUSCLE; DIAGNOSTIC IMAGING; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; TISSUE SURVIVAL; TREATMENT OUTCOME;

HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL REPERFUSION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; ST ELEVATION MYOCARDIAL INFARCTION; TISSUE SURVIVAL; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 85051744094     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.030693     Document Type: Article

References (104)

1. Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med. 2012;366:54-63. doi: 10.1056/NEJMra1112570.
2. Pedersen F, Butrymovich V, Kelbak H, Wachtell K, Helqvist S, Kastrup J, Holmvang L, Clemmensen P, Engstrøm T, Grande P, Saunamäki K, Jørgensen E. Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol. 2014;64:2101-2108. doi: 10.1016/j.jacc.2014.08.037.
3. Ezekowitz JA, Kaul P, Bakal JA, Armstrong PW, Welsh RC, McAlister FA. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol. 2009;53:13-20. doi: 10.1016/j.jacc.2008.08.067.
4. Bulluck H, Foin N, Tan JW, Low AF, Sezer M, Hausenloy DJ. Invasive assessment of the coronary microcirculation in reperfused ST-segment-elevation myocardial infarction patients: where do we stand?. Circ Cardiovasc Interv. 2017;10:e004373.
5. Bulluck H, Yellon DM, Hausenloy DJ. Reducing myocardial infarct size: Challenges and future opportunities. Heart. 2016;102:341-348. doi: 10.1136/heartjnl-2015-307855.
6. Bulluck H, Hammond-Haley M, Weinmann S, Martinez-Macias R, Hausenloy DJ. Myocardial infarct size by CMR in clinical cardioprotection studies: Insights from randomized controlled trials. JACC Cardiovasc Imaging. 2017;10:230-240. doi: 10.1016/j.jcmg.2017.01.008.
7. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P; ESC Scientific Document Group. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119-177. doi: 10.1093/eurheartj/ehx393.
8. Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, Kim RJ, von Knobelsdorff-Brenkenhoff F, Kramer CM, Pennell DJ, Plein S, Nagel E. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013;15:35. doi: 10.1186/1532-429X-15-35.
9. Kim HW, Farzaneh-Far A, Kim RJ. Cardiovascular magnetic resonance in patients with myocardial infarction: Current and emerging applications. J Am Coll Cardiol. 2009;55:1-16. doi: 10.1016/j.jacc.2009.06.059.
10. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study. Lancet. 2003;361:374-379. doi: 10.1016/S0140-6736(03)12389-6.
11. Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, Mascherbauer J, Nezafat R, Salerno M, Schelbert EB, Taylor AJ, Thompson R, Ugander M, van Heeswijk RB, Friedrich MG. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2∗extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017;19:75. doi: 10.1186/s12968-017-0389-8.
12. Carrick D, Haig C, Ahmed N, Rauhalammi S, Clerfond G, Carberry J, Mordi I, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay MM, Mahrous A, Welsh P, Sattar N, Ford I, Oldroyd KG, Radjenovic A, Berry C. Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-segment elevation myocardial infarction: Pathophysiological insights and clinical implications. J Am Heart Assoc. 2016;5:e002834.
13. Fernández-Jiménez R, Barreiro-Pérez M, Martin-García A, Sánchez-González J, Agüero J, Galán-Arriola C, García-Prieto J, Díaz-Pelaez E, Vara P, Martinez I, Zamarro I, Garde B, Sanz J, Fuster V, Sánchez PL, Ibanez B. Dynamic edematous response of the human heart to myocardial infarction: Implications for assessing myocardial area at risk and salvage. Circulation. 2017;136:1288-1300. doi: 10.1161/CIRCULATIONAHA.116.025582.
14. Carrick D, Haig C, Ahmed N, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay MM, Davie A, Mahrous A, Mordi I, Rauhalammi S, Sattar N, Welsh P, Radjenovic A, Ford I, Oldroyd KG, Berry C. Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction: Relation to microvascular obstruction and prognostic significance. Circ Cardiovasc Imaging. 2016;9:e004148. doi: 10.1161/CIRCIMAGING.115.004148.
15. Bulluck H, Rosmini S, Abdel-Gadir A, White SK, Bhuva AN, Treibel TA, Fontana M, Ramlall M, Hamarneh A, Sirker A, Herrey AS, Manisty C, Yellon DM, Kellman P, Moon JC, Hausenloy DJ. Residual myocardial iron following intramyocardial hemorrhage during the convalescent phase of reperfused ST-segment-elevation myocardial infarction and adverse left ventricular remodeling. Circ Cardiovasc Imaging. 2016;9:e004940.
16. Bulluck H, Rosmini S, Abdel-Gadir A, White SK, Bhuva AN, Treibel TA, Fontana M, Gonzalez-Lopez E, Reant P, Ramlall M, Hamarneh A, Sirker A, Herrey AS, Manisty C, Yellon DM, Kellman P, Moon JC, Hausenloy DJ. Automated extracellular volume fraction mapping provides insights into the pathophysiology of left ventricular remodeling post-reperfused STelevation myocardial infarction. J Am Heart Assoc. 2016;5:e003555.
17. Carberry J, Carrick D, Haig C, Rauhalammi SM, Ahmed N, Mordi I, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay M, Davie A, Mahrous A, Ford I, Sattar N, Welsh P, Radjenovic A, Oldroyd KG, Berry C. Remote zone extracellular volume and left ventricular remodeling in survivors of ST-elevation myocardial infarction. Hypertension. 2016;68:385-391. doi: 10.1161/HYPERTENSIONAHA.116.07222.
18. Bradley WG Jr. MR appearance of hemorrhage in the brain. Radiology. 1993;189:15-26. doi: 10.1148/radiology.189.1.8372185.
19. Carrick D, Haig C, Rauhalammi S, Ahmed N, Mordi I, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay M, Mahrous A, Ford I, Tzemos N, Sattar N, Welsh P, Radjenovic A, Oldroyd KG, Berry C. Prognostic significance of infarct core pathology revealed by quantitative noncontrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. Eur Heart J. 2016;37:1044-1059. doi: 10.1093/eurheartj/ehv372.
20. Kumar A, Green JD, Sykes JM, Ephrat P, Carson JJ, Mitchell AJ, Wisenberg G, Friedrich MG. Detection and quantification of myocardial reperfusion hemorrhage using T2∗-weighted CMR. JACC Cardiovasc Imaging. 2011;4:1274-1283. doi: 10.1016/j.jcmg.2011.08.016.
21. Kali A, Tang RL, Kumar A, Min JK, Dharmakumar R. Detection of acute reperfusion myocardial hemorrhage with cardiac MR imaging: T2 versus T2. Radiology. 2013;269:387-395. doi: 10.1148/radiol.13122397.
22. Ortiz-Pérez JT, Meyers SN, Lee DC, Kansal P, Klocke FJ, Holly TA, Davidson CJ, Bonow RO, Wu E. Angiographic estimates of myocardium at risk during acute myocardial infarction: Validation study using cardiac magnetic resonance imaging. Eur Heart J. 2007;28:1750-1758. doi: 10.1093/eurheartj/ehm212.
23. Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF Jr, Arai AE. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: Histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation. 2006;113:1865-1870. doi: 10.1161/CIRCULATIONAHA.105.576025.
24. Berry C, Kellman P, Mancini C, Chen MY, Bandettini WP, Lowrey T, Hsu LY, Aletras AH, Arai AE. Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. Circ Cardiovasc Imaging. 2010;3:527-535. doi: 10.1161/CIRCIMAGING.109.900761.
25. Verhaert D, Thavendiranathan P, Giri S, Mihai G, Rajagopalan S, Simonetti OP, Raman SV. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging. 2011;4:269-278. doi: 10.1016/j.jcmg.2010.09.023.
26. Ugander M, Bagi PS, Oki AJ, Chen B, Hsu LY, Aletras AH, Shah S, Greiser A, Kellman P, Arai AE. Myocardial edema as detected by precontrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging. 2012;5:596-603. doi: 10.1016/j.jcmg.2012.01.016.
27. Bulluck H, White SK, Rosmini S, Bhuva A, Treibel TA, Fontana M, Abdel-Gadir A, Herrey A, Manisty C, Wan SM, Groves A, Menezes L, Moon JC, Hausenloy DJ. T1 mapping and T2 mapping at 3T for quantifying the area at risk in reperfused STEMI patients. J Cardiovasc Magn Reson. 2015;17:73. doi: 10.1186/s12968-015-0173-6.
28. Matsumoto H, Matsuda T, Miyamoto K, Shimada T, Mikuri M, Hiraoka Y. Peri-infarct zone on early contrast-enhanced CMR imaging in patients with acute myocardial infarction. JACC Cardiovasc Imaging. 2011;4:610-618. doi: 10.1016/j.jcmg.2011.03.015.
29. Hammer-Hansen S, Leung SW, Hsu LY, Wilson JR, Taylor J, Greve AM, Thune JJ, Køber L, Kellman P, Arai AE. Early gadolinium enhancement for determination of area at risk: A preclinical validation study. JACC Cardiovasc Imaging. 2017;10:130-139. doi: 10.1016/j.jcmg.2016.04.009.
30. Kumar A, Beohar N, Arumana JM, Larose E, Li D, Friedrich MG, Dharmakumar R. CMR imaging of edema in myocardial infarction using cine balanced steady-state free precession. JACC Cardiovasc Imaging. 2011;4:1265-1273. doi: 10.1016/j.jcmg.2011.04.024.
31. Nordlund D, Klug G, Heiberg E, Koul S, Larsen TH, Hoffmann P, Metzler B, Erlinge D, Atar D, Aletras AH, Carlsson M, Engblom H, Arheden H. Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction. Eur Heart J Cardiovasc Imaging. 2016;17:744-753. doi: 10.1093/ehjci/jew027.
32. Nordlund D, Kanski M, Jablonowski R, Koul S, Erlinge D, Carlsson M, Engblom H, Aletras AH, Arheden H. Experimental validation of contrastenhanced SSFP cine CMR for quantification of myocardium at risk in acute myocardial infarction. J Cardiovasc Magn Reson. 2017;19:12. doi: 10.1186/s12968-017-0325-y.
33. Dall'Armellina E, Piechnik SK, Ferreira VM, Si QL, Robson MD, Francis JM, Cuculi F, Kharbanda RK, Banning AP, Choudhury RP, Karamitsos TD, Neubauer S. Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson. 2012;14:15. doi: 10.1186/1532-429X-14-15.
34. Bøtker HE, Kaltoft AK, Pedersen SF, Kim WY. Measuring myocardial salvage. Cardiovasc Res. 2012;94:266-275. doi: 10.1093/cvr/cvs081.
35. Engblom H, Heiberg E, Erlinge D, Jensen SE, Nordrehaug JE, Dubois-Randé JL, Halvorsen S, Hoffmann P, Koul S, Carlsson M, Atar D, Arheden H. Sample size in clinical cardioprotection trials using myocardial salvage index, infarct size, or biochemical markers as endpoint. J Am Heart Assoc. 2016;5:e002708. doi: 10.1161/JAHA.115.002708.
36. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002.
37. Krug A, Du Mesnil de Rochemont R, Korb G. Blood supply of the myocardium after temporary coronary occlusion. Circ Res. 1966;19:57-62.
38. Bulluck H, Rosmini S, Abdel-Gadir A, Bhuva AN, Treibel TA, Fontana M, Gonzalez-Lopez E, Ramlall M, Hamarneh A, Sirker A, Herrey AS, Manisty C, Yellon DM, Moon JC, Hausenloy DJ. Diagnostic performance of T1and T2mapping to detect intramyocardial hemorrhage in reperfused STsegment elevation myocardial infarction (STEMI) patients. J Magn Reson Imaging. 2017;46:877-886. doi: 10.1002/jmri.25638.
39. Hamirani YS, Wong A, Kramer CM, Salerno M. Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: A systematic review and meta-analysis. JACC Cardiovasc Imaging. 2014;7:940-952. doi: 10.1016/j.jcmg.2014.06.012.
40. Arai AE. Magnetic resonance imaging for area at risk, myocardial infarction, and myocardial salvage. J Cardiovasc Pharmacol Ther. 2011;16:313-320. doi: 10.1177/1074248411412378.
41. Bulluck H, Hammond-Haley M, Fontana M, Knight DS, Sirker A, Herrey AS, Manisty C, Kellman P, Moon JC, Hausenloy DJ. Quantification of both the area at risk and acute myocardial infarct size in ST-segment elevation myocardial infarction using T1-mapping. J Cardiovasc Magn Reson. 2017;19:57. doi: 10.1186/s12968-017-0370-6.
42. Kali A, Choi EY, Sharif B, Kim YJ, Bi X, Spottiswoode B, Cokic I, Yang HJ, Tighiouart M, Conte AH, Li D, Berman DS, Choi BW, Chang HJ, Dharmakumar R. Native T1 mapping by 3-T CMR imaging for characterization of chronic myocardial infarctions. JACC Cardiovasc Imaging. 2015;8:1019-1030. doi: 10.1016/j.jcmg.2015.04.018.
43. Liu D, Borlotti A, Viliani D, Jerosch-Herold M, Alkhalil M, De Maria GL, Fahrni G, Dawkins S, Wijesurendra R, Francis J, Ferreira V, Piechnik S, Robson MD, Banning A, Choudhury R, Neubauer S, Channon K, Kharbanda R, Dall'Armellina E. CMR native T1 mapping allows differentiation of reversible versus irreversible myocardial damage in ST-segment-elevation myocardial infarction: An OxAMI Study (Oxford Acute Myocardial Infarction). Circ Cardiovasc Imaging. 2017;10:e005986.
44. Garg P, Broadbent D, Swoboda P, Foley JR, Fent GJ, Musa TA, Ripley DP, Erhayiem B, Dobson LE, McDiarmid A, Haaf P, Kidambi A, van der Geest RJ, Greenwood JP, Plein S. Acute infarct extracellular volume mapping to quantify myocardial area at risk and chronic infarct size on cardiovascular magnetic resonance imaging. Circ Cardiovasc Imaging. 2017;10:e006182.
45. Bulluck H, Hausenloy DJ. Mapping myocardial salvage index by extracellular volume fraction: Are we there yet?. Circ Cardiovasc Imaging. 2017;10:e006680.
46. Kidambi A, Motwani M, Uddin A, Ripley DP, McDiarmid AK, Swoboda PP, Broadbent DA, Musa TA, Erhayiem B, Leader J, Croisille P, Clarysse P, Greenwood JP, Plein S. Myocardial extracellular volume estimation by CMR predicts functional recovery following acute MI. JACC Cardiovasc Imaging. 2017;10:989-999. doi: 10.1016/j.jcmg.2016.06.015.
47. Ørn S, Manhenke C, Greve OJ, Larsen AI, Bonarjee VV, Edvardsen T, Dickstein K. Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention. Eur Heart J. 2009;30:1978-1985. doi: 10.1093/eurheartj/ehp219.
48. van Kranenburg M, Magro M, Thiele H, de Waha S, Eitel I, Cochet A, Cottin Y, Atar D, Buser P, Wu E, Lee D, Bodi V, Klug G, Metzler B, Delewi R, Bernhardt P, Rottbauer W, Boersma E, Zijlstra F, van Geuns RJ. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging. 2014;7:930-939. doi: 10.1016/j.jcmg.2014.05.010.
49. de Waha S, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I, Ben-Yehuda O, Jenkins P, Thiele H, Stone GW. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: An individual patient data pooled analysis from seven randomized trials. Eur Heart J. 2017;38:3502-3510. doi: 10.1093/eurheartj/ehx414.
50. Westman PC, Lipinski MJ, Luger D, Waksman R, Bonow RO, Wu E, Epstein SE. Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol. 2016;67:2050-2060. doi: 10.1016/j.jacc.2016.01.073.
51. Bulluck H, Go YY, Crimi G, Ludman AJ, Rosmini S, Abdel-Gadir A, Bhuva AN, Treibel TA, Fontana M, Pica S, Raineri C, Sirker A, Herrey AS, Manisty C, Groves A, Moon JC, Hausenloy DJ. Defining left ventricular remodeling following acute ST-segment elevation myocardial infarction using cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2017;19:26. doi: 10.1186/s12968-017-0343-9.
52. Kali A, Kumar A, Cokic I, Tang RL, Tsaftaris SA, Friedrich MG, Dharmakumar R. Chronic manifestation of postreperfusion intramyocardial hemorrhage as regional iron deposition: A cardiovascular magnetic resonance study with ex vivo validation. Circ Cardiovasc Imaging. 2013;6:218-228. doi: 10.1161/CIRCIMAGING.112.000133.
53. Kali A, Cokic I, Tang R, Dohnalkova A, Kovarik L, Yang HJ, Kumar A, Prato FS, Wood JC, Underhill D, Marban E, Dharmakumar R. Persistent microvascular obstruction after myocardial infarction culminates in the confluence of ferric iron oxide crystals, proinflammatory burden, and adverse remodeling. Circ Cardiovasc Imaging. 2016;9:e004996.
54. Roghi A, Poggiali E, Duca L, Mafrici A, Pedrotti P, Paccagnini S, Brenna S, Galli A, Consonni D, Cappellini MD. Role of non-transferrin-bound iron in the pathogenesis of cardiotoxicity in patients with ST-elevation myocardial infarction assessed by cardiac magnetic resonance imaging. Int J Cardiol. 2015;199:326-332. doi: 10.1016/j.ijcard.2015.07.056.
55. Carberry J, Carrick D, Haig C, Ahmed N, Mordi I, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay M, Davie A, Mahrous A, Ford I, Sattar N, Welsh P, Radjenovic A, Oldroyd KG, Berry C. Persistent iron within the infarct core after ST-segment elevation myocardial infarction: Implications for left ventricular remodeling and health outcomes [published online ahead of print November 10, 2017]. JACC Cardiovasc Imaging. doi: 10.1016/j.jcmg.2017.08.027. https://www.sciencedirect.com/ science/article/pii/S1936878X17309166-via%3Dihub.
56. Reinstadler SJ, Stiermaier T, Liebetrau J, Fuernau G, Eitel C, de Waha S, Desch S, Reil JC, Poss J, Metzler B, Lucke C, Gutberlet M, Schuler G, Thiele H, Eitel I. Prognostic significance of remote myocardium alterations assessed by quantitative noncontrast T1 mapping in ST-segment elevation myocardial infarction. JACC Cardiovasc Imaging. 2018;11:411-419. doi: 10.1016/j.jcmg.2017.03.015.
57. Carrick D, Haig C, Rauhalammi S, Ahmed N, Mordi I, McEntegart M, Petrie MC, Eteiba H, Lindsay M, Watkins S, Hood S, Davie A, Mahrous A, Sattar N, Welsh P, Tzemos N, Radjenovic A, Ford I, Oldroyd KG, Berry C. Pathophysiology of LV remodeling in survivors of STEMI: Inflammation, remote myocardium, and prognosis. JACC Cardiovasc Imaging. 2015;8:779-789. doi: 10.1016/j.jcmg.2015.03.007.
58. Garg P, Broadbent DA, Swoboda PP, Foley JRJ, Fent GJ, Musa TA, Ripley DP, Erhayiem B, Dobson LE, McDiarmid AK, Haaf P, Kidambi A, Crandon S, Chew PG, van der Geest RJ, Greenwood JP, Plein S. Extra-cellular expansion in the normal, non-infarcted myocardium is associated with worsening of regional myocardial function after acute myocardial infarction. J Cardiovasc Magn Reson. 2017;19:73. doi: 10.1186/s12968-017-0384-0.
59. Stone GW, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, Maehara A, Eitel I, Granger CB, Jenkins PL, Nichols M, Ben-Yehuda O. Relationship between infarct size and outcomes following primary PCI: Patient-level analysis from 10 randomized trials. J Am Coll Cardiol. 2016;67:1674-1683. doi: 10.1016/j.jacc.2016.01.069.
60. Symons R, Pontone G, Schwitter J, Francone M, Iglesias JF, Barison A, Zalewski J, de Luca L, Degrauwe S, Claus P, Guglielmo M, Nessler J, Carbone I, Ferro G, Durak M, Magistrelli P, Lo Presti A, Aquaro GD, Eeckhout E, Roguelov C, Andreini D, Vogt P, Guaricci AI, Mushtaq S, Lorenzoni V, Muller O, Desmet W, Agati L, Janssens S, Bogaert J, Masci PG. Longterm incremental prognostic value of cardiovascular magnetic resonance after ST-segment elevation myocardial infarction: A study of the collaborative registry on CMR in STEMI [published online ahead of print August 11, 2017]. JACC Cardiovasc Imaging. doi: 10.1016/j.jcmg.2017.05.023. https://www.sciencedirect.com/science/article/pii/S1936878X17306204?. via%3Dihub.
61. Eitel I, de Waha S, Wöhrle J, Fuernau G, Lurz P, Pauschinger M, Desch S, Schuler G, Thiele H. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014;64:1217-1226. doi: 10.1016/j.jacc.2014.06.1194.
62. Amier RP, Tijssen RYG, Teunissen PFA, Fernandez-Jimenez R, Pizarro G, Garcia-Lunar I, Bastante T, van de Ven PM, Beek AM, Smulders MW, Bekkers S, van Royen N, Ibanez B, Nijveldt R. Predictors of intramyocardial hemorrhage after reperfused ST-segment elevation myocardial infarction. J Am Heart Assoc. 2017;6:e005651.
63. Kanazawa H, Tseliou E, Malliaras K, Yee K, Dawkins JF, De Couto G, Smith RR, Kreke M, Seinfeld J, Middleton RC, Gallet R, Cheng K, Luthringer D, Valle I, Chowdhury S, Fukuda K, Makkar RR, Marbán L, Marbán E. Cellular postconditioning: Allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction. Circ Heart Fail. 2015;8:322-332. doi: 10.1161/CIRCHEARTFAILURE.114.001484.
64. Higgins CB, Herfkens R, Lipton MJ, Sievers R, Sheldon P, Kaufman L, Crooks LE. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: Alterations in magnetic relaxation times. Am J Cardiol. 1983;52:184-188.
65. Friedrich MG. Myocardial edema: A new clinical entity?. Nat Rev Cardiol. 2010;7:292-296. doi: 10.1038/nrcardio.2010.28.
66. Tilak GS, Hsu LY, Hoyt RF Jr, Arai AE, Aletras AH. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction. Invest Radiol. 2008;43:7-15. doi: 10.1097/RLI.0b013e3181558822.
67. Ubachs JF, Engblom H, Koul S, Kanski M, Andersson P, van der Pals J, Carlsson M, Erlinge D, Arheden H. Myocardium at risk can be determined by ex vivo T2-weighted magnetic resonance imaging even in the presence of gadolinium: Comparison to myocardial perfusion single photon emission computed tomography. Eur Heart J Cardiovasc Imaging. 2013;14:261-268. doi: 10.1093/ehjci/jes142.
68. Kim HW, Van Assche L, Jennings RB, Wince WB, Jensen CJ, Rehwald WG, Wendell DC, Bhatti L, Spatz DM, Parker MA, Jenista ER, Klem I, Crowley AL, Chen EL, Judd RM, Kim RJ. Relationship of T2-weighted MRI myocardial hyperintensity and the ischemic area at risk. Circ Res. 2015;117:254-265. doi: 10.1161/CIRCRESAHA.117.305771.
69. Bulluck H, White SK, Fröhlich GM, Casson SG, O'Meara C, Newton A, Nicholas J, Weale P, Wan SM, Sirker A, Moon JC, Yellon DM, Groves A, Menezes L, Hausenloy DJ. Quantifying the area at risk in reperfused ST-segment-elevation myocardial infarction patients using hybrid cardiac positron emission tomography-magnetic resonance imaging. Circ Cardiovasc Imaging. 2016;9:e003900. doi: 10.1161/CIRCIMAGING.115.003900.
70. Hammer-Hansen S, Ugander M, Hsu LY, Taylor J, Thune JJ, Køber L, Kellman P, Arai AE. Distinction of salvaged and infarcted myocardium within the ischaemic area at risk with T2 mapping. Eur Heart J Cardiovasc Imaging. 2014;15:1048-1053. doi: 10.1093/ehjci/jeu073.
71. Dall'Armellina E, Karia N, Lindsay AC, Karamitsos TD, Ferreira V, Robson MD, Kellman P, Francis JM, Forfar C, Prendergast BD, Banning AP, Channon KM, Kharbanda RK, Neubauer S, Choudhury RP. Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index. Circ Cardiovasc Imaging. 2011;4:228-236. doi: 10.1161/CIRCIMAGING.111.963421.
72. Carlsson M, Ubachs JF, Hedström E, Heiberg E, Jovinge S, Arheden H. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: Quantitative assessment during follow-up and validation with single-photon emission computed tomography. JACC Cardiovasc Imaging. 2009;2:569-576. doi: 10.1016/j.jcmg.2008.11.018.
73. Fernández-Jiménez R, Sánchez-González J, Agüero J, García-Prieto J, López-Martín GJ, García-Ruiz JM, Molina-Iracheta A, Rosselló X, Fernández-Friera L, Pizarro G, García-Álvarez A, Dall'Armellina E, Macaya C, Choudhury RP, Fuster V, Ibáñez B. Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: Imaging and histological tissue characterization. J Am Coll Cardiol. 2015;65:315-323. doi: 10.1016/j.jacc.2014.11.004.
74. Fernández-Jiménez R, García-Prieto J, Sánchez-González J, Agüero J, López-Martín GJ, Galán-Arriola C, Molina-Iracheta A, Doohan R, Fuster V, Ibáñez B. Pathophysiology underlying the bimodal edema phenomenon after myocardial ischemia/reperfusion. J Am Coll Cardiol. 2015;66:816-828. doi: 10.1016/j.jacc.2015.06.023.
75. Thuny F, Lairez O, Roubille F, Mewton N, Rioufol G, Sportouch C, Sanchez I, Bergerot C, Thibault H, Cung TT, Finet G, Argaud L, Revel D, Derumeaux G, Bonnefoy-Cudraz E, Elbaz M, Piot C, Ovize M, Croisille P. Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2012;59:2175-2181. doi: 10.1016/j.jacc.2012.03.026.
76. White SK, Frohlich GM, Sado DM, Maestrini V, Fontana M, Treibel TA, Tehrani S, Flett AS, Meier P, Ariti C, Davies JR, Moon JC, Yellon DM, Hausenloy DJ. Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2015;8(pt B):178-188. doi: 10.1016/j.jcin.2014.05.015.
77. Eitel I, Stiermaier T, Rommel KP, Fuernau G, Sandri M, Mangner N, Linke A, Erbs S, Lurz P, Boudriot E, Mende M, Desch S, Schuler G, Thiele H. Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: The randomized LIPSIA CONDITIONING trial. Eur Heart J. 2015;36:3049-3057. doi: 10.1093/eurheartj/ehv463.
78. Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, García-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández-Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, Pérez de Prado A, Fernández-Campos MJ, Casado I, García-Rubira JC, García-Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández-Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster V. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial. Circulation. 2013;128:1495-1503. doi: 10.1161/CIRCULATIONAHA.113.003653.
79. Lønborg J, Vejlstrup N, Kelbak H, Bøtker HE, Kim WY, Mathiasen AB, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Thuesen L, Krusell LR, Jensen JS, Køber L, Treiman M, Holst JJ, Engstrøm T. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J. 2012;33:1491-1499. doi: 10.1093/eurheartj/ehr309.
80. Ibrahim T, Hackl T, Nekolla SG, Breuer M, Feldmair M, Schömig A, Schwaiger M. Acute myocardial infarction: Serial cardiac MR imaging shows a decrease in delayed enhancement of the myocardium during the 1st week after reperfusion. Radiology. 2010;254:88-97. doi: 10.1148/radiol.09090660.
81. Jablonowski R, Engblom H, Kanski M, Nordlund D, Koul S, van der Pals J, Englund E, Heiberg E, Erlinge D, Carlsson M, Arheden H. Contrastenhanced CMR overestimates early myocardial infarct size: Mechanistic insights using ECV measurements on day 1 and day 7. JACC Cardiovasc Imaging. 2015;8:1379-1389. doi: 10.1016/j.jcmg.2015.08.015.
82. Hammer-Hansen S, Bandettini WP, Hsu LY, Leung SW, Shanbhag S, Mancini C, Greve AM, Køber L, Thune JJ, Kellman P, Arai AE. Mechanisms for overestimating acute myocardial infarct size with gadolinium-enhanced cardiovascular magnetic resonance imaging in humans: A quantitative and kinetic study. Eur Heart J Cardiovasc Imaging. 2016;17:76-84. doi: 10.1093/ehjci/jev123.
83. Rodríguez-Palomares JF, Ortiz-Pérez JT, Lee DC, Bucciarelli-Ducci C, Tejedor P, Bonow RO, Wu E. Time elapsed after contrast injection is crucial to determine infarct transmurality and myocardial functional recovery after an acute myocardial infarction. J Cardiovasc Magn Reson. 2015;17:43. doi: 10.1186/s12968-015-0139-8.
84. Mather AN, Fairbairn TA, Artis NJ, Greenwood JP, Plein S. Timing of cardiovascular MR imaging after acute myocardial infarction: Effect on estimates of infarct characteristics and prediction of late ventricular remodeling. Radiology. 2011;261:116-126. doi: 10.1148/radiol.11110228.
85. Engblom H, Hedström E, Heiberg E, Wagner GS, Pahlm O, Arheden H. Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the peri-infarction zone: One-year follow-up by MRI. Circ Cardiovasc Imaging. 2009;2:47-55. doi: 10.1161/CIRCIMAGING.108.802199.
86. Lønborg J, Vejlstrup N, Kelbak H, Holmvang L, Jørgensen E, Helqvist S, Saunamäki K, Ahtarovski KA, Bøtker HE, Kim WY, Clemmensen P, Engstrøm T. Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: An observational study. Eur Heart J Cardiovasc Imaging. 2013;14:387-395. doi: 10.1093/ehjci/jes271.
87. Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, Kansal P, Carr JC, Holly TA, Lloyd-Jones D, Klocke FJ, Bonow RO. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: Prospective cohort study. Heart. 2008;94:730-736. doi: 10.1136/hrt.2007.122622.
88. Thiele H, Kappl MJ, Conradi S, Niebauer J, Hambrecht R, Schuler G. Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol. 2006;47:1641-1645. doi: 10.1016/j.jacc.2005.11.065.
89. Bulluck H, Rosmini S, Abdel-Gadir A, Bhuva AN, Treibel TA, Fontana M, Weinmann S, Sirker A, Herrey AS, Manisty C, Moon JC, Hausenloy DJ. Impact of microvascular obstruction on semiautomated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonance. Open Heart. 2016;3:e000535. doi: 10.1136/openhrt-2016-000535.
90. Yang HJ, Sharif B, Pang J, Kali A, Bi X, Cokic I, Li D, Dharmakumar R. Free-breathing, motion-corrected, highly efficient whole heart T2 mapping at 3T with hybrid radial-cartesian trajectory. Magn Reson Med. 2016;75:126-136. doi: 10.1002/mrm.25576.
91. Kellman P, Xue H, Spottiswoode BS, Sandino CM, Hansen MS, Abdel-Gadir A, Treibel TA, Rosmini S, Mancini C, Bandettini WP, McGill LA, Gatehouse P, Moon JC, Pennell DJ, Arai AE. Free-breathing T2∗ mapping using respiratory motion corrected averaging. J Cardiovasc Magn Reson. 2015;17:3. doi: 10.1186/s12968-014-0106-9.
92. Kellman P, Arai AE. Cardiac imaging techniques for physicians: Late enhancement. J Magn Reson Imaging. 2012;36:529-542. doi: 10.1002/jmri.23605.
93. Seropian IM, Toldo S, Van Tassell BW, Abbate A. Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. J Am Coll Cardiol. 2014;63:1593-1603. doi: 10.1016/j.jacc.2014.01.014.
94. Stiermaier T, Jobs A, de Waha S, Fuernau G, Poss J, Desch S, Thiele H, Eitel I. Optimized prognosis assessment in ST-segment-elevation myocardial infarction using a cardiac magnetic resonance imaging risk score. Circ Cardiovasc Imaging. 2017;10:e006774.
95. Pontone G, Guaricci AI, Andreini D, Ferro G, Guglielmo M, Baggiano A, Fusini L, Muscogiuri G, Lorenzoni V, Mushtaq S, Conte E, Annoni A, Formenti A, Mancini ME, Carita P, Verdecchia M, Pica S, Fazzari F, Cosentino N, Marenzi G, Rabbat MG, Agostoni P, Bartorelli AL, Pepi M, Masci PG. Prognostic Stratification of Patients With ST-Segment-Elevation Myocardial Infarction (PROSPECT): A cardiac magnetic resonance study. Circ Cardiovasc Imaging. 2017;10:e006428.
96. Dharmakumar R. "Rusty hearts": Is it time to rethink iron chelation therapies in post-myocardial-infarction setting?. Circ Cardiovasc Imaging. 2016;9:e005541.
97. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions. 2013 ACCF/ AHA guideline for the management of ST-elevation myocardial infarction: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2013;82:E1-E27. doi: 10.1002/ccd.24776.
98. Zaman S, Kovoor P. Sudden cardiac death early after myocardial infarction: Pathogenesis, risk stratification, and primary prevention. Circulation. 2014;129:2426-2435. doi: 10.1161/CIRCULATIONAHA.113.007497.
99. Pouleur AC, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, Belenkov YN, Mareev V, Velazquez EJ, Rouleau JL, Maggioni AP, Køber L, Califf RM, McMurray JJ, Pfeffer MA, Solomon SD; VALIANT Investigators. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation. 2010;122:597-602. doi: 10.1161/CIRCULATIONAHA.110.940619.
100. Izquierdo M, Ruiz-Granell R, Bonanad C, Chaustre F, Gomez C, Ferrero A, Lopez-Lereu P, Monmeneu JV, Nuñez J, Chorro FJ, Bodi V. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction. Circ Cardiovasc Imaging. 2013;6:755-761. doi: 10.1161/CIRCIMAGING.113.000702.
101. Watanabe E, Abbasi SA, Heydari B, Coelho-Filho OR, Shah R, Neilan TG, Murthy VL, Mongeon FP, Barbhaiya C, Jerosch-Herold M, Blankstein R, Hatabu H, van der Geest RJ, Stevenson WG, Kwong RY. Infarct tissue heterogeneity by contrast-enhanced magnetic resonance imaging is a novel predictor of mortality in patients with chronic coronary artery disease and left ventricular dysfunction. Circ Cardiovasc Imaging. 2014;7:887-894. doi: 10.1161/CIRCIMAGING.113.001293.
102. Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B, Parker MA, Judd RM, Kim RJ. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol. 2012;60:408-420. doi: 10.1016/j.jacc.2012.02.070.
103. Cokic I, Kali A, Yang HJ, Yee R, Tang R, Tighiouart M, Wang X, Jackman WS, Chugh SS, White JA, Dharmakumar R. Iron-sensitive cardiac magnetic resonance imaging for prediction of ventricular arrhythmia risk in patients with chronic myocardial infarction: Early evidence. Circ Cardiovasc Imaging. 2015;8:e003642.
104. Treibel TA, Fontana M, Maestrini V, Castelletti S, Rosmini S, Simpson J, Nasis A, Bhuva AN, Bulluck H, Abdel-Gadir A, White SK, Manisty C, Spottiswoode BS, Wong TC, Piechnik SK, Kellman P, Robson MD, Schelbert EB, Moon JC. Automatic measurement of the myocardial interstitium: Synthetic extracellular volume quantification without hematocrit sampling. JACC Cardiovasc Imaging. 2016;9:54-63. doi: 10.1016/j.jcmg.2015.11.008.